BARCLAYS PLC

Position in NVAX — Novavax Inc

CIK 312069 LONDON, X0

Back to NVAX Full portfolio

Position in NVAX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,327,908

-$8,367,473 QoQ

Shares Held

140,967

-88.2% QoQ

Ownership

0.085%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#55

of 263 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVAX Over Time

Shares Held

Position Value (USD)

Derivatives in NVAX

reported options exposure · as of Mar 31, 2024

CallValue

$239,000

CallShares

50,000

PutValue

$478,000

PutShares

100,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,706,140,734 across 455 Biotechnology names. NVAX ranks #100 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	733,274	$364,239,192
2	REGN	Regeneron Pharmaceuticals, Inc.	256,192	$159,745,957
3	IONS	Ionis Pharmaceuticals Inc	1,603,136	$127,112,653
4	ARGX	Argenx SE	134,427	$124,717,337
5	MRNA	Moderna, Inc.	1,035,126	$72,489,872
6	BBIO	BridgeBio Pharma, Inc.	714,423	$53,210,224
7	TGTX	Tg Therapeutics, Inc.	957,848	$52,624,168
8	DNTH	Dianthus Therapeutics, Inc. /DE/	431,753	$42,087,281

All Filings in NVAX

Export CSV

41 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,327,908	140,967	-88.2%	Shares	Defined	2026-08-14
2026-03-31	$9,695,381	1,191,079	+8.1%	Shares	Defined	2026-05-15
2025-12-31	$7,407,455	1,102,300	+108.8%	Shares	Sole	2026-02-13
2025-09-30	$4,578,079	528,037	-12.5%	Shares	Sole	2026-03-31
2025-06-30	$3,800,889	603,316	+103.6%	Shares	Defined	2026-02-27
2025-03-31	$1,899,056	296,265	-28.3%	Shares	Defined	2026-03-17
2024-12-31	$3,324,273	413,467	-41.7%	Shares	Defined	2026-03-19
2024-09-30	$8,961,981	709,579	+73.9%	Shares	Defined	2026-03-31
2024-06-30	$5,164,670	407,952	+61.0%	Shares	Sole	2026-03-23
2024-03-31	$478,000	100,000	-74.4%	Put	Sole	2026-03-24
2024-03-31	$1,211,373	253,426	-69.2%	Shares	Sole	2026-03-24
2024-03-31	$239,000	50,000	-90.0%	Call	Sole	2026-03-24
2023-12-31	$1,872,000	390,000	+5170.3%	Put	Sole	2026-03-24
2023-12-31	$2,400,000	500,000	-37.5%	Call	Sole	2026-03-24
2023-12-31	$3,944,043	821,676	+48.4%	Shares	Defined	2026-03-24
2023-09-30	$4,009,436	553,790	+2.3%	Shares	Sole	2026-03-26
2023-06-30	$4,023,752	541,555	+15.7%	Shares	Sole	2026-03-27
2023-03-31	$3,242,878	467,948	+0.1%	Shares	Sole	2026-03-30
2023-03-31	$51,282	7,400	-22.1%	Put	Sole	2026-03-30
2023-03-31	$5,544,000	800,000	+357.1%	Call	Sole	2026-03-30
2022-12-31	$97,660	9,500	-94.6%	Put	Sole	2026-03-30
2022-12-31	$4,805,559	467,467	+32.0%	Shares	Defined	2026-03-30
2022-12-31	$1,799,000	175,000	+5.5%	Call	Sole	2026-03-30
2022-09-30	$6,446,803	354,220	+142.2%	Shares	Defined	2022-11-03
2022-06-30	$8,995,107	174,900	—	Put	Sole	2022-08-12
2022-06-30	$7,522,715	146,271	-26.6%	Shares	Defined	2022-08-12
2022-03-31	$14,685,292	199,393	+4.6%	Shares	Sole	2022-05-16
2021-12-31	$27,265,420	190,574	+87.9%	Shares	Sole	2022-02-14
2021-12-31	$23,721,006	165,800	+643.5%	Call	Sole	2022-02-14
2021-09-30	$4,623,013	22,300	-84.4%	Call	Sole	2021-11-09
2021-09-30	$21,026,621	101,426	-51.4%	Shares	Sole	2021-11-09
2021-06-30	$44,278,734	208,557	+135.5%	Shares	Sole	2021-08-13
2021-06-30	$30,381,561	143,100	+615.5%	Call	Sole	2021-08-13
2021-03-31	$3,626,200	20,000	+270.4%	Call	Sole	2021-05-13
2021-03-31	$16,059,531	88,575	+15.0%	Shares	Sole	2021-05-13
2020-12-31	$8,590,952	77,042	-0.9%	Shares	Sole	2021-02-11
2020-12-31	$602,154	5,400	-64.5%	Call	Sole	2021-02-11
2020-09-30	$8,420,743	77,718	-10.8%	Shares	Sole	2020-11-12
2020-09-30	$1,646,920	15,200	—	Call	Sole	2020-11-12
2020-06-30	$7,259,868	87,101	+96.7%	Shares	Sole	2020-08-12
2020-03-31	$601,240	44,274	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.